Sabra Health Care REIT, Inc. (SBRA) stock
SBRANasdaqReal Estate Investment TrustsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3059% above fair value
$20.25−0.10 (-0.49%)
Close on Nov 17, 2026Market cap $5.17BP/E 77.9Yield 5.93%
Sabra Health Care REIT r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Sabra Health Care REIT
Sabra Health Care REIT has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?